Nutritional status in patients with COVID-19 and cancer: the experience of the National Cancer Institute in Mexico

被引:3
作者
Perez Camargo, Dana Aline [1 ,7 ]
Vargas Gutierrez, Gaspar [1 ]
Rivera Franco, Monica M. [6 ]
Labana Ramirez, Anabel [1 ]
Castro Herrera, Monserrat [1 ]
Urbalejo Ceniceros, Victor Itai [2 ]
Copca Mendoza, Erika Thalia [1 ]
Loyola Serrano, Osiris [1 ]
Baltazar Luna, Erendira [1 ]
Meneses Garcia, Abelardo [4 ]
Herrera Gomez, Angel [5 ]
Gonzalez Enciso, Aaron [3 ]
Sevilla Gonzalez, Maria de la Luz [7 ]
机构
[1] Inst Nacl Cancerol, Dept Nutr, Ave San Fernando 22,Belisario Dominguez Secc XVI, Mexico City 14080, DF, Mexico
[2] Inst Nacl Cancerol, Dept Hematol, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Dept Surg, Mexico City, DF, Mexico
[4] Inst Nacl Cancerol, Dept Gen Directorship, Mexico City, DF, Mexico
[5] Inst Nacl Cancerol, Dept Med Directorship, Mexico City, DF, Mexico
[6] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hematol & Oncol, Mexico City, DF, Mexico
[7] Inst Politecn Nacl, Fac Med, Postgrad & Res Dept, Mexico City, DF, Mexico
关键词
Body mass index; Cancer; COVID-19; Mortality; Nutrition;
D O I
10.20960/nh.03683
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: nutritional status might vary according to different underlying illnesses such as cancer or infectious diseases, including COVID-19. In this context, data from developing countries remain scarce. Objectives: the objective of this study was to assess the nutritional status and outcomes of Mexican cancer patients diagnosed with COVID-19 at a tertiary care center. Methods: this was a retrospective study including 121 consecutive cancer patients diagnosed with COVID-19 at the National Cancer Institute, Mexico City, during four months. Results: the most frequent oncological diagnoses were gynecological (19 %) and hematological (17 %). Most patients were overweight (35 %). In the univariate analysis, >= 65 years, intubation, hypoalbuminemia, high creatinine, lymphopenia, nutrition-impact symptoms, and ECOG 2-4 were statistically associated with lower survival. The median survival of the cohort was 41 days. Conclusions: to our best knowledge, this is the first study of its kind performed in Mexico, and as other studies from other regions, our results might aid in identifying cancer patients most at risk for severe COVID-19, and could be potentially useful to enhance public health messaging on self-isolation and social distancing among Mexican cancer patients.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [21] The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients – a national cancer centre experience
    Sharon S. Poh
    Boon Fei Tan
    Fang Yue Yong
    Kam Weng Fong
    Joseph T. S. Wee
    Terence W. K. Tan
    Melvin L. K. Chua
    Kiattisa Sommat
    Fu Qiang Wang
    Yoke Lim Soong
    Holistic Integrative Oncology, 2 (1):
  • [22] Experience of a National Cancer Institute-Designated Community Outreach and Engagement Program in Supporting Communities During the COVID-19 Pandemic
    Austin, Jessica D.
    Burke, Kimberly
    Argov, Erica J. Lee
    Hillyer, Grace C.
    Schmitt, Karen M.
    McDonald, Jasmine
    Shelton, Rachel C.
    Terry, Mary Beth
    Tehranifar, Parisa
    JOURNAL OF COMMUNITY HEALTH, 2022, 47 (05) : 862 - 870
  • [23] The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients
    Zeilinger, Elisabeth Lucia
    Knefel, Matthias
    Schneckenreiter, Carmen
    Pietschnig, Jakob
    Lubowitzki, Simone
    Unseld, Matthias
    Fuereder, Thorsten
    Bartsch, Rupert
    Masel, Eva Katharina
    Adamidis, Feroniki
    Kum, Lea
    Kiesewetter, Barbara
    Zoechbauer-Mueller, Sabine
    Raderer, Markus
    Krauth, Maria Theresa
    Staber, Philipp B.
    Valent, Peter
    Gaiger, Alexander
    INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY, 2023, 23 (04)
  • [24] Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19
    Ekinci, Iskender
    Uzun, Hafize
    Utku, Irem Kirac
    Ozkan, Hanise
    Buyukkaba, Mitat
    Cinar, Ahmet
    Akarsu, Murat
    Kumbasar, Abdulbaki
    Tabak, Omur
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2022, 92 (01) : 4 - 12
  • [25] Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center
    Fernandes, Gisele Aparecida
    Feriani, Diego
    Franca e Silva, Ivan Leonardo Avelino
    Mendonca e Silva, Diego Rodrigues
    Arantes, Paola Engelmann
    Canteras, Juliana da Silva
    da Silva, Rodrigo Reghini
    Curado, Maria Paula
    SEMINARS IN ONCOLOGY, 2021, 48 (02) : 171 - 180
  • [26] Cancer patients with COVID-19: does prior nutritional risk associated with cancer indicate a poor prognosis for COVID-19?
    De Oliveira, Livia Costa
    Da Costa Rosa, Karla Santos
    Pedrosa, Aline Pereira
    Da Silva, Naira Freire
    Dos Santos, Lara Azevedo
    Maria Wiegert, Emanuelly Varea
    EINSTEIN-SAO PAULO, 2023, 21 : 1 - 10
  • [27] Outcomes of Cancer Patients with COVID-19: The Virginia Commonwealth University Experience
    Willard, Patrick J.
    Hang, Yiwei
    Olasehinde, Temitayo
    Zeid, Naji Bou
    Defor, Edem
    Bandyopadhyay, Dipankar
    Yazbeck, Victor
    CANCER INVESTIGATION, 2023, 41 (05) : 456 - 466
  • [28] Cancer patients affected by COVID-19: Experience from Milan, Lombardy
    Bogani, Giorgio
    Ditto, Antonino
    Bosio, Sara
    Brusadelli, Claudia
    Raspagliesi, Francesco
    GYNECOLOGIC ONCOLOGY, 2020, 158 (02) : 262 - 265
  • [29] COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience
    So, Alfred Chung Pui
    McGrath, Harriet
    Ting, Jonathan
    Srikandarajah, Krishnie
    Germanou, Styliani
    Moss, Charlotte
    Russell, Beth
    Monroy-Iglesias, Maria
    Dolly, Saoirse
    Irshad, Sheeba
    Van Hemelrijck, Mieke
    Enting, Deborah
    CANCERS, 2021, 13 (14)
  • [30] SARS-CoV-2 Vaccination in Patients with Cancer and COVID-19 in Mexico
    Barrientos-Flores, Corazon
    Vilar-Compte, Diana
    Martinez-Rivera, Nancy
    Villasenor-Echavarri, Rodrigo
    Martin-Onraet, Alexandra
    VACCINES, 2024, 12 (10)